enow.com Web Search

  1. Ads

    related to: experimental prostate cancer drugs

Search results

  1. Results from the WOW.Com Content Network
  2. Experimental cancer treatment - Wikipedia

    en.wikipedia.org/wiki/Experimental_cancer_treatment

    Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.

  3. Seviteronel - Wikipedia

    en.wikipedia.org/wiki/Seviteronel

    Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. [1]

  4. AOH1996 - Wikipedia

    en.wikipedia.org/wiki/AOH1996

    AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. [1] [2] [3] [4]

  5. Janux Therapeutics surges on upbeat trial data for prostate ...

    www.aol.com/news/janux-therapeutics-surges-trial...

    The candidate, JANX007, reduced prostate-specific (PSA) antigen levels in a majority of the 23 patients who received the drug, the company said late on Monday, adding that deeper reductions were ...

  6. Zibotentan - Wikipedia

    en.wikipedia.org/wiki/Zibotentan

    Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca. [1] It is an endothelin receptor antagonist. [2] Zibotentan was granted fast track status for the treatment of prostate cancer by the FDA. It failed a phase III clinical trial for prostate cancer, [3] but other trials are ...

  7. STAMPEDE (clinical trial) - Wikipedia

    en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

    Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.

  8. Masofaniten - Wikipedia

    en.wikipedia.org/wiki/Masofaniten

    Masofaniten, also known by its developmental code name EPI-7386, is an N-terminal domain antiandrogen, or antagonist of the N-terminal domain (NTD) of the androgen receptor (AR), which is under development for the treatment of prostate cancer.

  9. Experts Face Off on Prostate Cancer Drugs - AOL

    www.aol.com/news/2010-04-11-should-men-take-drug...

    For premium support please call: 800-290-4726 more ways to reach us

  1. Ads

    related to: experimental prostate cancer drugs